Global Rapid Diagnostic Testing for Influenza Market Research Report 2026(Status and Outlook)
Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Rapid Diagnostic Testing for Influenza market size was estimated at USD 1351.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Rapid Diagnostic Testing for Influenza market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rapid Diagnostic Testing for Influenza market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rapid Diagnostic Testing for Influenza market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rapid Diagnostic Testing for Influenza Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rapid Diagnostic Testing for Influenza, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Rapid Diagnostic Testing for Influenza market size was estimated at USD 1351.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Rapid Diagnostic Testing for Influenza market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rapid Diagnostic Testing for Influenza market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rapid Diagnostic Testing for Influenza market.
Global Rapid Diagnostic Testing for Influenza Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- BD
- Abbot (Alere)
- Quidel
- Roche
- Thermo Fisher Scientific
- Meridian Bioscience
- Analytik Jena
- Princeton BioMeditech Corporation
- BioMerieux
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
- DiaSorin (Focus Diagnostics)
- Wondfo
- Beijing Wantai Biological Pharmacy
Market Segmentation (by Type)
- Digital RIDTs
- Conventional RIDT
Market Segmentation (by Application)
- Hospitals
- POCT
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Rapid Diagnostic Testing for Influenza Market
Overview of the regional outlook of the Rapid Diagnostic Testing for Influenza Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rapid Diagnostic Testing for Influenza Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rapid Diagnostic Testing for Influenza, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Rapid Diagnostic Testing for Influenza
1.2 Key Market Segments
1.2.1 Rapid Diagnostic Testing for Influenza Segment by Type
1.2.2 Rapid Diagnostic Testing for Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Rapid Diagnostic Testing for Influenza Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Rapid Diagnostic Testing for Influenza Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Rapid Diagnostic Testing for Influenza Product Life Cycle
3.3 Global Rapid Diagnostic Testing for Influenza Sales by Manufacturers (2020-2025)
3.4 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Manufacturers (2020-2025)
3.5 Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Rapid Diagnostic Testing for Influenza Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Rapid Diagnostic Testing for Influenza Market Competitive Situation and Trends
3.8.1 Rapid Diagnostic Testing for Influenza Market Concentration Rate
3.8.2 Global 5 and 10 Largest Rapid Diagnostic Testing for Influenza Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RAPID DIAGNOSTIC TESTING FOR INFLUENZA INDUSTRY CHAIN ANALYSIS
4.1 Rapid Diagnostic Testing for Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Rapid Diagnostic Testing for Influenza Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Rapid Diagnostic Testing for Influenza Market
5.7 ESG Ratings of Leading Companies
6 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rapid Diagnostic Testing for Influenza Sales Market Share by Type (2020-2025)
6.3 Global Rapid Diagnostic Testing for Influenza Market Size by Type (2020-2025)
6.4 Global Rapid Diagnostic Testing for Influenza Price by Type (2020-2025)
7 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rapid Diagnostic Testing for Influenza Market Sales by Application (2020-2025)
7.3 Global Rapid Diagnostic Testing for Influenza Market Size (M USD) by Application (2020-2025)
7.4 Global Rapid Diagnostic Testing for Influenza Sales Growth Rate by Application (2020-2025)
8 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET SALES BY REGION
8.1 Global Rapid Diagnostic Testing for Influenza Sales by Region
8.1.1 Global Rapid Diagnostic Testing for Influenza Sales by Region
8.1.2 Global Rapid Diagnostic Testing for Influenza Sales Market Share by Region
8.2 Global Rapid Diagnostic Testing for Influenza Market Size by Region
8.2.1 Global Rapid Diagnostic Testing for Influenza Market Size by Region
8.2.2 Global Rapid Diagnostic Testing for Influenza Market Size by Region
8.3 North America
8.3.1 North America Rapid Diagnostic Testing for Influenza Sales by Country
8.3.2 North America Rapid Diagnostic Testing for Influenza Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Rapid Diagnostic Testing for Influenza Sales by Country
8.4.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Rapid Diagnostic Testing for Influenza Sales by Region
8.5.2 Asia Pacific Rapid Diagnostic Testing for Influenza Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Rapid Diagnostic Testing for Influenza Sales by Country
8.6.2 South America Rapid Diagnostic Testing for Influenza Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Rapid Diagnostic Testing for Influenza Sales by Region
8.7.2 Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET PRODUCTION BY REGION
9.1 Global Production of Rapid Diagnostic Testing for Influenza by Region(2020-2025)
9.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Region (2020-2025)
9.3 Global Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Rapid Diagnostic Testing for Influenza Production
9.4.1 North America Rapid Diagnostic Testing for Influenza Production Growth Rate (2020-2025)
9.4.2 North America Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Rapid Diagnostic Testing for Influenza Production
9.5.1 Europe Rapid Diagnostic Testing for Influenza Production Growth Rate (2020-2025)
9.5.2 Europe Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Rapid Diagnostic Testing for Influenza Production (2020-2025)
9.6.1 Japan Rapid Diagnostic Testing for Influenza Production Growth Rate (2020-2025)
9.6.2 Japan Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Rapid Diagnostic Testing for Influenza Production (2020-2025)
9.7.1 China Rapid Diagnostic Testing for Influenza Production Growth Rate (2020-2025)
9.7.2 China Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BD
10.1.1 BD Basic Information
10.1.2 BD Rapid Diagnostic Testing for Influenza Product Overview
10.1.3 BD Rapid Diagnostic Testing for Influenza Product Market Performance
10.1.4 BD Business Overview
10.1.5 BD SWOT Analysis
10.1.6 BD Recent Developments
10.2 Abbot (Alere)
10.2.1 Abbot (Alere) Basic Information
10.2.2 Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Overview
10.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Market Performance
10.2.4 Abbot (Alere) Business Overview
10.2.5 Abbot (Alere) SWOT Analysis
10.2.6 Abbot (Alere) Recent Developments
10.3 Quidel
10.3.1 Quidel Basic Information
10.3.2 Quidel Rapid Diagnostic Testing for Influenza Product Overview
10.3.3 Quidel Rapid Diagnostic Testing for Influenza Product Market Performance
10.3.4 Quidel Business Overview
10.3.5 Quidel SWOT Analysis
10.3.6 Quidel Recent Developments
10.4 Roche
10.4.1 Roche Basic Information
10.4.2 Roche Rapid Diagnostic Testing for Influenza Product Overview
10.4.3 Roche Rapid Diagnostic Testing for Influenza Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Thermo Fisher Scientific
10.5.1 Thermo Fisher Scientific Basic Information
10.5.2 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Overview
10.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Market Performance
10.5.4 Thermo Fisher Scientific Business Overview
10.5.5 Thermo Fisher Scientific Recent Developments
10.6 Meridian Bioscience
10.6.1 Meridian Bioscience Basic Information
10.6.2 Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Overview
10.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Market Performance
10.6.4 Meridian Bioscience Business Overview
10.6.5 Meridian Bioscience Recent Developments
10.7 Analytik Jena
10.7.1 Analytik Jena Basic Information
10.7.2 Analytik Jena Rapid Diagnostic Testing for Influenza Product Overview
10.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Product Market Performance
10.7.4 Analytik Jena Business Overview
10.7.5 Analytik Jena Recent Developments
10.8 Princeton BioMeditech Corporation
10.8.1 Princeton BioMeditech Corporation Basic Information
10.8.2 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Overview
10.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Market Performance
10.8.4 Princeton BioMeditech Corporation Business Overview
10.8.5 Princeton BioMeditech Corporation Recent Developments
10.9 BioMerieux
10.9.1 BioMerieux Basic Information
10.9.2 BioMerieux Rapid Diagnostic Testing for Influenza Product Overview
10.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Product Market Performance
10.9.4 BioMerieux Business Overview
10.9.5 BioMerieux Recent Developments
10.10 Sekisui Diagnostics
10.10.1 Sekisui Diagnostics Basic Information
10.10.2 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Overview
10.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Market Performance
10.10.4 Sekisui Diagnostics Business Overview
10.10.5 Sekisui Diagnostics Recent Developments
10.11 Response Biomedical
10.11.1 Response Biomedical Basic Information
10.11.2 Response Biomedical Rapid Diagnostic Testing for Influenza Product Overview
10.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Product Market Performance
10.11.4 Response Biomedical Business Overview
10.11.5 Response Biomedical Recent Developments
10.12 SA Scientific
10.12.1 SA Scientific Basic Information
10.12.2 SA Scientific Rapid Diagnostic Testing for Influenza Product Overview
10.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Product Market Performance
10.12.4 SA Scientific Business Overview
10.12.5 SA Scientific Recent Developments
10.13 DiaSorin (Focus Diagnostics)
10.13.1 DiaSorin (Focus Diagnostics) Basic Information
10.13.2 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Overview
10.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Market Performance
10.13.4 DiaSorin (Focus Diagnostics) Business Overview
10.13.5 DiaSorin (Focus Diagnostics) Recent Developments
10.14 Wondfo
10.14.1 Wondfo Basic Information
10.14.2 Wondfo Rapid Diagnostic Testing for Influenza Product Overview
10.14.3 Wondfo Rapid Diagnostic Testing for Influenza Product Market Performance
10.14.4 Wondfo Business Overview
10.14.5 Wondfo Recent Developments
10.15 Beijing Wantai Biological Pharmacy
10.15.1 Beijing Wantai Biological Pharmacy Basic Information
10.15.2 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Overview
10.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Market Performance
10.15.4 Beijing Wantai Biological Pharmacy Business Overview
10.15.5 Beijing Wantai Biological Pharmacy Recent Developments
11 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET FORECAST BY REGION
11.1 Global Rapid Diagnostic Testing for Influenza Market Size Forecast
11.2 Global Rapid Diagnostic Testing for Influenza Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Rapid Diagnostic Testing for Influenza Market Size Forecast by Country
11.2.3 Asia Pacific Rapid Diagnostic Testing for Influenza Market Size Forecast by Region
11.2.4 South America Rapid Diagnostic Testing for Influenza Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Rapid Diagnostic Testing for Influenza by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Rapid Diagnostic Testing for Influenza Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Rapid Diagnostic Testing for Influenza by Type (2026-2035)
12.1.2 Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Rapid Diagnostic Testing for Influenza by Type (2026-2035)
12.2 Global Rapid Diagnostic Testing for Influenza Market Forecast by Application (2026-2035)
12.2.1 Global Rapid Diagnostic Testing for Influenza Sales (K Units) Forecast by Application
12.2.2 Global Rapid Diagnostic Testing for Influenza Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Rapid Diagnostic Testing for Influenza
1.2 Key Market Segments
1.2.1 Rapid Diagnostic Testing for Influenza Segment by Type
1.2.2 Rapid Diagnostic Testing for Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Rapid Diagnostic Testing for Influenza Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Rapid Diagnostic Testing for Influenza Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Rapid Diagnostic Testing for Influenza Product Life Cycle
3.3 Global Rapid Diagnostic Testing for Influenza Sales by Manufacturers (2020-2025)
3.4 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Manufacturers (2020-2025)
3.5 Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Rapid Diagnostic Testing for Influenza Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Rapid Diagnostic Testing for Influenza Market Competitive Situation and Trends
3.8.1 Rapid Diagnostic Testing for Influenza Market Concentration Rate
3.8.2 Global 5 and 10 Largest Rapid Diagnostic Testing for Influenza Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RAPID DIAGNOSTIC TESTING FOR INFLUENZA INDUSTRY CHAIN ANALYSIS
4.1 Rapid Diagnostic Testing for Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Rapid Diagnostic Testing for Influenza Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Rapid Diagnostic Testing for Influenza Market
5.7 ESG Ratings of Leading Companies
6 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rapid Diagnostic Testing for Influenza Sales Market Share by Type (2020-2025)
6.3 Global Rapid Diagnostic Testing for Influenza Market Size by Type (2020-2025)
6.4 Global Rapid Diagnostic Testing for Influenza Price by Type (2020-2025)
7 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rapid Diagnostic Testing for Influenza Market Sales by Application (2020-2025)
7.3 Global Rapid Diagnostic Testing for Influenza Market Size (M USD) by Application (2020-2025)
7.4 Global Rapid Diagnostic Testing for Influenza Sales Growth Rate by Application (2020-2025)
8 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET SALES BY REGION
8.1 Global Rapid Diagnostic Testing for Influenza Sales by Region
8.1.1 Global Rapid Diagnostic Testing for Influenza Sales by Region
8.1.2 Global Rapid Diagnostic Testing for Influenza Sales Market Share by Region
8.2 Global Rapid Diagnostic Testing for Influenza Market Size by Region
8.2.1 Global Rapid Diagnostic Testing for Influenza Market Size by Region
8.2.2 Global Rapid Diagnostic Testing for Influenza Market Size by Region
8.3 North America
8.3.1 North America Rapid Diagnostic Testing for Influenza Sales by Country
8.3.2 North America Rapid Diagnostic Testing for Influenza Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Rapid Diagnostic Testing for Influenza Sales by Country
8.4.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Rapid Diagnostic Testing for Influenza Sales by Region
8.5.2 Asia Pacific Rapid Diagnostic Testing for Influenza Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Rapid Diagnostic Testing for Influenza Sales by Country
8.6.2 South America Rapid Diagnostic Testing for Influenza Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Rapid Diagnostic Testing for Influenza Sales by Region
8.7.2 Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET PRODUCTION BY REGION
9.1 Global Production of Rapid Diagnostic Testing for Influenza by Region(2020-2025)
9.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Region (2020-2025)
9.3 Global Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Rapid Diagnostic Testing for Influenza Production
9.4.1 North America Rapid Diagnostic Testing for Influenza Production Growth Rate (2020-2025)
9.4.2 North America Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Rapid Diagnostic Testing for Influenza Production
9.5.1 Europe Rapid Diagnostic Testing for Influenza Production Growth Rate (2020-2025)
9.5.2 Europe Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Rapid Diagnostic Testing for Influenza Production (2020-2025)
9.6.1 Japan Rapid Diagnostic Testing for Influenza Production Growth Rate (2020-2025)
9.6.2 Japan Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Rapid Diagnostic Testing for Influenza Production (2020-2025)
9.7.1 China Rapid Diagnostic Testing for Influenza Production Growth Rate (2020-2025)
9.7.2 China Rapid Diagnostic Testing for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BD
10.1.1 BD Basic Information
10.1.2 BD Rapid Diagnostic Testing for Influenza Product Overview
10.1.3 BD Rapid Diagnostic Testing for Influenza Product Market Performance
10.1.4 BD Business Overview
10.1.5 BD SWOT Analysis
10.1.6 BD Recent Developments
10.2 Abbot (Alere)
10.2.1 Abbot (Alere) Basic Information
10.2.2 Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Overview
10.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Market Performance
10.2.4 Abbot (Alere) Business Overview
10.2.5 Abbot (Alere) SWOT Analysis
10.2.6 Abbot (Alere) Recent Developments
10.3 Quidel
10.3.1 Quidel Basic Information
10.3.2 Quidel Rapid Diagnostic Testing for Influenza Product Overview
10.3.3 Quidel Rapid Diagnostic Testing for Influenza Product Market Performance
10.3.4 Quidel Business Overview
10.3.5 Quidel SWOT Analysis
10.3.6 Quidel Recent Developments
10.4 Roche
10.4.1 Roche Basic Information
10.4.2 Roche Rapid Diagnostic Testing for Influenza Product Overview
10.4.3 Roche Rapid Diagnostic Testing for Influenza Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Thermo Fisher Scientific
10.5.1 Thermo Fisher Scientific Basic Information
10.5.2 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Overview
10.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Market Performance
10.5.4 Thermo Fisher Scientific Business Overview
10.5.5 Thermo Fisher Scientific Recent Developments
10.6 Meridian Bioscience
10.6.1 Meridian Bioscience Basic Information
10.6.2 Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Overview
10.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Market Performance
10.6.4 Meridian Bioscience Business Overview
10.6.5 Meridian Bioscience Recent Developments
10.7 Analytik Jena
10.7.1 Analytik Jena Basic Information
10.7.2 Analytik Jena Rapid Diagnostic Testing for Influenza Product Overview
10.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Product Market Performance
10.7.4 Analytik Jena Business Overview
10.7.5 Analytik Jena Recent Developments
10.8 Princeton BioMeditech Corporation
10.8.1 Princeton BioMeditech Corporation Basic Information
10.8.2 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Overview
10.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Market Performance
10.8.4 Princeton BioMeditech Corporation Business Overview
10.8.5 Princeton BioMeditech Corporation Recent Developments
10.9 BioMerieux
10.9.1 BioMerieux Basic Information
10.9.2 BioMerieux Rapid Diagnostic Testing for Influenza Product Overview
10.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Product Market Performance
10.9.4 BioMerieux Business Overview
10.9.5 BioMerieux Recent Developments
10.10 Sekisui Diagnostics
10.10.1 Sekisui Diagnostics Basic Information
10.10.2 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Overview
10.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Market Performance
10.10.4 Sekisui Diagnostics Business Overview
10.10.5 Sekisui Diagnostics Recent Developments
10.11 Response Biomedical
10.11.1 Response Biomedical Basic Information
10.11.2 Response Biomedical Rapid Diagnostic Testing for Influenza Product Overview
10.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Product Market Performance
10.11.4 Response Biomedical Business Overview
10.11.5 Response Biomedical Recent Developments
10.12 SA Scientific
10.12.1 SA Scientific Basic Information
10.12.2 SA Scientific Rapid Diagnostic Testing for Influenza Product Overview
10.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Product Market Performance
10.12.4 SA Scientific Business Overview
10.12.5 SA Scientific Recent Developments
10.13 DiaSorin (Focus Diagnostics)
10.13.1 DiaSorin (Focus Diagnostics) Basic Information
10.13.2 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Overview
10.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Market Performance
10.13.4 DiaSorin (Focus Diagnostics) Business Overview
10.13.5 DiaSorin (Focus Diagnostics) Recent Developments
10.14 Wondfo
10.14.1 Wondfo Basic Information
10.14.2 Wondfo Rapid Diagnostic Testing for Influenza Product Overview
10.14.3 Wondfo Rapid Diagnostic Testing for Influenza Product Market Performance
10.14.4 Wondfo Business Overview
10.14.5 Wondfo Recent Developments
10.15 Beijing Wantai Biological Pharmacy
10.15.1 Beijing Wantai Biological Pharmacy Basic Information
10.15.2 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Overview
10.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Market Performance
10.15.4 Beijing Wantai Biological Pharmacy Business Overview
10.15.5 Beijing Wantai Biological Pharmacy Recent Developments
11 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET FORECAST BY REGION
11.1 Global Rapid Diagnostic Testing for Influenza Market Size Forecast
11.2 Global Rapid Diagnostic Testing for Influenza Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Rapid Diagnostic Testing for Influenza Market Size Forecast by Country
11.2.3 Asia Pacific Rapid Diagnostic Testing for Influenza Market Size Forecast by Region
11.2.4 South America Rapid Diagnostic Testing for Influenza Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Rapid Diagnostic Testing for Influenza by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Rapid Diagnostic Testing for Influenza Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Rapid Diagnostic Testing for Influenza by Type (2026-2035)
12.1.2 Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Rapid Diagnostic Testing for Influenza by Type (2026-2035)
12.2 Global Rapid Diagnostic Testing for Influenza Market Forecast by Application (2026-2035)
12.2.1 Global Rapid Diagnostic Testing for Influenza Sales (K Units) Forecast by Application
12.2.2 Global Rapid Diagnostic Testing for Influenza Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Rapid Diagnostic Testing for Influenza Market Size by Type (M USD)
Table 4. Global Rapid Diagnostic Testing for Influenza Market Size by Application
Table 5. Rapid Diagnostic Testing for Influenza Market Size Comparison by Region (M USD)
Table 6. Global Rapid Diagnostic Testing for Influenza Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Rapid Diagnostic Testing for Influenza Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Rapid Diagnostic Testing for Influenza Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2025)
Table 11. Global Market Rapid Diagnostic Testing for Influenza Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Rapid Diagnostic Testing for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Rapid Diagnostic Testing for Influenza Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Rapid Diagnostic Testing for Influenza Sales by Type (K Units)
Table 27. Global Rapid Diagnostic Testing for Influenza Market Size by Type (M USD)
Table 28. Global Rapid Diagnostic Testing for Influenza Sales (K Units) by Type (2020-2025)
Table 29. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Type (2020-2025)
Table 30. Global Rapid Diagnostic Testing for Influenza Market Size (M USD) by Type (2020-2025)
Table 31. Global Rapid Diagnostic Testing for Influenza Market Share by Type (2020-2025)
Table 32. Global Rapid Diagnostic Testing for Influenza Price (USD/Unit) by Type (2020-2025)
Table 33. Global Rapid Diagnostic Testing for Influenza Sales (K Units) by Application
Table 34. Global Rapid Diagnostic Testing for Influenza Market Size by Application
Table 35. Global Rapid Diagnostic Testing for Influenza Sales by Application (2020-2025) & (K Units)
Table 36. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Application (2020-2025)
Table 37. Global Rapid Diagnostic Testing for Influenza Market Size by Application (2020-2025) & (M USD)
Table 38. Global Rapid Diagnostic Testing for Influenza Market Share by Application (2020-2025)
Table 39. Global Rapid Diagnostic Testing for Influenza Sales Growth Rate by Application (2020-2025)
Table 40. Global Rapid Diagnostic Testing for Influenza Sales by Region (2020-2025) & (K Units)
Table 41. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Region (2020-2025)
Table 42. Global Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025) & (M USD)
Table 43. Global Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025)
Table 44. North America Rapid Diagnostic Testing for Influenza Sales by Country (2020-2025) & (K Units)
Table 45. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Rapid Diagnostic Testing for Influenza Sales by Country (2020-2025) & (K Units)
Table 47. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Rapid Diagnostic Testing for Influenza Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025) & (M USD)
Table 50. South America Rapid Diagnostic Testing for Influenza Sales by Country (2020-2025) & (K Units)
Table 51. South America Rapid Diagnostic Testing for Influenza Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025) & (M USD)
Table 54. Global Rapid Diagnostic Testing for Influenza Production (K Units) by Region(2020-2025)
Table 55. Global Rapid Diagnostic Testing for Influenza Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Region (2020-2025)
Table 57. Global Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. BD Basic Information
Table 63. BD Rapid Diagnostic Testing for Influenza Product Overview
Table 64. BD Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. BD Business Overview
Table 66. BD SWOT Analysis
Table 67. BD Recent Developments
Table 68. Abbot (Alere) Basic Information
Table 69. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Overview
Table 70. Abbot (Alere) Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Abbot (Alere) Business Overview
Table 72. Abbot (Alere) SWOT Analysis
Table 73. Abbot (Alere) Recent Developments
Table 74. Quidel Basic Information
Table 75. Quidel Rapid Diagnostic Testing for Influenza Product Overview
Table 76. Quidel Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Quidel Business Overview
Table 78. Quidel SWOT Analysis
Table 79. Quidel Recent Developments
Table 80. Roche Basic Information
Table 81. Roche Rapid Diagnostic Testing for Influenza Product Overview
Table 82. Roche Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Roche Business Overview
Table 84. Roche Recent Developments
Table 85. Thermo Fisher Scientific Basic Information
Table 86. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Overview
Table 87. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Recent Developments
Table 90. Meridian Bioscience Basic Information
Table 91. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Overview
Table 92. Meridian Bioscience Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Meridian Bioscience Business Overview
Table 94. Meridian Bioscience Recent Developments
Table 95. Analytik Jena Basic Information
Table 96. Analytik Jena Rapid Diagnostic Testing for Influenza Product Overview
Table 97. Analytik Jena Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Analytik Jena Business Overview
Table 99. Analytik Jena Recent Developments
Table 100. Princeton BioMeditech Corporation Basic Information
Table 101. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Overview
Table 102. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Princeton BioMeditech Corporation Business Overview
Table 104. Princeton BioMeditech Corporation Recent Developments
Table 105. BioMerieux Basic Information
Table 106. BioMerieux Rapid Diagnostic Testing for Influenza Product Overview
Table 107. BioMerieux Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. BioMerieux Business Overview
Table 109. BioMerieux Recent Developments
Table 110. Sekisui Diagnostics Basic Information
Table 111. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Overview
Table 112. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sekisui Diagnostics Business Overview
Table 114. Sekisui Diagnostics Recent Developments
Table 115. Response Biomedical Basic Information
Table 116. Response Biomedical Rapid Diagnostic Testing for Influenza Product Overview
Table 117. Response Biomedical Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Response Biomedical Business Overview
Table 119. Response Biomedical Recent Developments
Table 120. SA Scientific Basic Information
Table 121. SA Scientific Rapid Diagnostic Testing for Influenza Product Overview
Table 122. SA Scientific Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. SA Scientific Business Overview
Table 124. SA Scientific Recent Developments
Table 125. DiaSorin (Focus Diagnostics) Basic Information
Table 126. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Overview
Table 127. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. DiaSorin (Focus Diagnostics) Business Overview
Table 129. DiaSorin (Focus Diagnostics) Recent Developments
Table 130. Wondfo Basic Information
Table 131. Wondfo Rapid Diagnostic Testing for Influenza Product Overview
Table 132. Wondfo Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Wondfo Business Overview
Table 134. Wondfo Recent Developments
Table 135. Beijing Wantai Biological Pharmacy Basic Information
Table 136. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Overview
Table 137. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Beijing Wantai Biological Pharmacy Business Overview
Table 139. Beijing Wantai Biological Pharmacy Recent Developments
Table 140. Global Rapid Diagnostic Testing for Influenza Sales Forecast by Region (2026-2035) & (K Units)
Table 141. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Rapid Diagnostic Testing for Influenza Sales Forecast by Country (2026-2035) & (K Units)
Table 143. North America Rapid Diagnostic Testing for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Rapid Diagnostic Testing for Influenza Sales Forecast by Country (2026-2035) & (K Units)
Table 145. Europe Rapid Diagnostic Testing for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Rapid Diagnostic Testing for Influenza Sales Forecast by Region (2026-2035) & (K Units)
Table 147. Asia Pacific Rapid Diagnostic Testing for Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Rapid Diagnostic Testing for Influenza Sales Forecast by Country (2026-2035) & (K Units)
Table 149. South America Rapid Diagnostic Testing for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Rapid Diagnostic Testing for Influenza Sales Forecast by Type (2026-2035) & (K Units)
Table 153. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Rapid Diagnostic Testing for Influenza Price Forecast by Type (2026-2035) & (USD/Unit)
Table 155. Global Rapid Diagnostic Testing for Influenza Sales (K Units) Forecast by Application (2026-2035)
Table 156. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Rapid Diagnostic Testing for Influenza Market Size by Type (M USD)
Table 4. Global Rapid Diagnostic Testing for Influenza Market Size by Application
Table 5. Rapid Diagnostic Testing for Influenza Market Size Comparison by Region (M USD)
Table 6. Global Rapid Diagnostic Testing for Influenza Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Rapid Diagnostic Testing for Influenza Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Rapid Diagnostic Testing for Influenza Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2025)
Table 11. Global Market Rapid Diagnostic Testing for Influenza Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Rapid Diagnostic Testing for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Rapid Diagnostic Testing for Influenza Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Rapid Diagnostic Testing for Influenza Sales by Type (K Units)
Table 27. Global Rapid Diagnostic Testing for Influenza Market Size by Type (M USD)
Table 28. Global Rapid Diagnostic Testing for Influenza Sales (K Units) by Type (2020-2025)
Table 29. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Type (2020-2025)
Table 30. Global Rapid Diagnostic Testing for Influenza Market Size (M USD) by Type (2020-2025)
Table 31. Global Rapid Diagnostic Testing for Influenza Market Share by Type (2020-2025)
Table 32. Global Rapid Diagnostic Testing for Influenza Price (USD/Unit) by Type (2020-2025)
Table 33. Global Rapid Diagnostic Testing for Influenza Sales (K Units) by Application
Table 34. Global Rapid Diagnostic Testing for Influenza Market Size by Application
Table 35. Global Rapid Diagnostic Testing for Influenza Sales by Application (2020-2025) & (K Units)
Table 36. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Application (2020-2025)
Table 37. Global Rapid Diagnostic Testing for Influenza Market Size by Application (2020-2025) & (M USD)
Table 38. Global Rapid Diagnostic Testing for Influenza Market Share by Application (2020-2025)
Table 39. Global Rapid Diagnostic Testing for Influenza Sales Growth Rate by Application (2020-2025)
Table 40. Global Rapid Diagnostic Testing for Influenza Sales by Region (2020-2025) & (K Units)
Table 41. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Region (2020-2025)
Table 42. Global Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025) & (M USD)
Table 43. Global Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025)
Table 44. North America Rapid Diagnostic Testing for Influenza Sales by Country (2020-2025) & (K Units)
Table 45. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Rapid Diagnostic Testing for Influenza Sales by Country (2020-2025) & (K Units)
Table 47. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Rapid Diagnostic Testing for Influenza Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025) & (M USD)
Table 50. South America Rapid Diagnostic Testing for Influenza Sales by Country (2020-2025) & (K Units)
Table 51. South America Rapid Diagnostic Testing for Influenza Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025) & (M USD)
Table 54. Global Rapid Diagnostic Testing for Influenza Production (K Units) by Region(2020-2025)
Table 55. Global Rapid Diagnostic Testing for Influenza Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Region (2020-2025)
Table 57. Global Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Rapid Diagnostic Testing for Influenza Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. BD Basic Information
Table 63. BD Rapid Diagnostic Testing for Influenza Product Overview
Table 64. BD Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. BD Business Overview
Table 66. BD SWOT Analysis
Table 67. BD Recent Developments
Table 68. Abbot (Alere) Basic Information
Table 69. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Overview
Table 70. Abbot (Alere) Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Abbot (Alere) Business Overview
Table 72. Abbot (Alere) SWOT Analysis
Table 73. Abbot (Alere) Recent Developments
Table 74. Quidel Basic Information
Table 75. Quidel Rapid Diagnostic Testing for Influenza Product Overview
Table 76. Quidel Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Quidel Business Overview
Table 78. Quidel SWOT Analysis
Table 79. Quidel Recent Developments
Table 80. Roche Basic Information
Table 81. Roche Rapid Diagnostic Testing for Influenza Product Overview
Table 82. Roche Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Roche Business Overview
Table 84. Roche Recent Developments
Table 85. Thermo Fisher Scientific Basic Information
Table 86. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Overview
Table 87. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Recent Developments
Table 90. Meridian Bioscience Basic Information
Table 91. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Overview
Table 92. Meridian Bioscience Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Meridian Bioscience Business Overview
Table 94. Meridian Bioscience Recent Developments
Table 95. Analytik Jena Basic Information
Table 96. Analytik Jena Rapid Diagnostic Testing for Influenza Product Overview
Table 97. Analytik Jena Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Analytik Jena Business Overview
Table 99. Analytik Jena Recent Developments
Table 100. Princeton BioMeditech Corporation Basic Information
Table 101. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Overview
Table 102. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Princeton BioMeditech Corporation Business Overview
Table 104. Princeton BioMeditech Corporation Recent Developments
Table 105. BioMerieux Basic Information
Table 106. BioMerieux Rapid Diagnostic Testing for Influenza Product Overview
Table 107. BioMerieux Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. BioMerieux Business Overview
Table 109. BioMerieux Recent Developments
Table 110. Sekisui Diagnostics Basic Information
Table 111. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Overview
Table 112. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sekisui Diagnostics Business Overview
Table 114. Sekisui Diagnostics Recent Developments
Table 115. Response Biomedical Basic Information
Table 116. Response Biomedical Rapid Diagnostic Testing for Influenza Product Overview
Table 117. Response Biomedical Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Response Biomedical Business Overview
Table 119. Response Biomedical Recent Developments
Table 120. SA Scientific Basic Information
Table 121. SA Scientific Rapid Diagnostic Testing for Influenza Product Overview
Table 122. SA Scientific Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. SA Scientific Business Overview
Table 124. SA Scientific Recent Developments
Table 125. DiaSorin (Focus Diagnostics) Basic Information
Table 126. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Overview
Table 127. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. DiaSorin (Focus Diagnostics) Business Overview
Table 129. DiaSorin (Focus Diagnostics) Recent Developments
Table 130. Wondfo Basic Information
Table 131. Wondfo Rapid Diagnostic Testing for Influenza Product Overview
Table 132. Wondfo Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Wondfo Business Overview
Table 134. Wondfo Recent Developments
Table 135. Beijing Wantai Biological Pharmacy Basic Information
Table 136. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Overview
Table 137. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Beijing Wantai Biological Pharmacy Business Overview
Table 139. Beijing Wantai Biological Pharmacy Recent Developments
Table 140. Global Rapid Diagnostic Testing for Influenza Sales Forecast by Region (2026-2035) & (K Units)
Table 141. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Rapid Diagnostic Testing for Influenza Sales Forecast by Country (2026-2035) & (K Units)
Table 143. North America Rapid Diagnostic Testing for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Rapid Diagnostic Testing for Influenza Sales Forecast by Country (2026-2035) & (K Units)
Table 145. Europe Rapid Diagnostic Testing for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Rapid Diagnostic Testing for Influenza Sales Forecast by Region (2026-2035) & (K Units)
Table 147. Asia Pacific Rapid Diagnostic Testing for Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Rapid Diagnostic Testing for Influenza Sales Forecast by Country (2026-2035) & (K Units)
Table 149. South America Rapid Diagnostic Testing for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Rapid Diagnostic Testing for Influenza Sales Forecast by Type (2026-2035) & (K Units)
Table 153. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Rapid Diagnostic Testing for Influenza Price Forecast by Type (2026-2035) & (USD/Unit)
Table 155. Global Rapid Diagnostic Testing for Influenza Sales (K Units) Forecast by Application (2026-2035)
Table 156. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Rapid Diagnostic Testing for Influenza
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rapid Diagnostic Testing for Influenza Market Size (M USD), 2025-2035
Figure 5. Global Rapid Diagnostic Testing for Influenza Market Size (M USD) (2020-2035)
Figure 6. Global Rapid Diagnostic Testing for Influenza Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Rapid Diagnostic Testing for Influenza Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Rapid Diagnostic Testing for Influenza Product Life Cycle
Figure 13. Rapid Diagnostic Testing for Influenza Sales Share by Manufacturers in 2025
Figure 14. Global Rapid Diagnostic Testing for Influenza Revenue Share by Manufacturers in 2025
Figure 15. Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Rapid Diagnostic Testing for Influenza Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Rapid Diagnostic Testing for Influenza Revenue in 2025
Figure 18. Industry Chain Map of Rapid Diagnostic Testing for Influenza
Figure 19. Global Rapid Diagnostic Testing for Influenza Market PEST Analysis
Figure 20. Global Rapid Diagnostic Testing for Influenza Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Rapid Diagnostic Testing for Influenza Market Share by Type
Figure 27. Sales Market Share of Rapid Diagnostic Testing for Influenza by Type (2020-2025)
Figure 28. Sales Market Share of Rapid Diagnostic Testing for Influenza by Type in 2025
Figure 29. Market Share of Rapid Diagnostic Testing for Influenza by Type (2020-2025)
Figure 30. Market Share of Rapid Diagnostic Testing for Influenza by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Rapid Diagnostic Testing for Influenza Market Share by Application
Figure 33. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Application (2020-2025)
Figure 34. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Application in 2025
Figure 35. Global Rapid Diagnostic Testing for Influenza Market Share by Application (2020-2025)
Figure 36. Global Rapid Diagnostic Testing for Influenza Market Share by Application in 2025
Figure 37. Global Rapid Diagnostic Testing for Influenza Sales Growth Rate by Application (2020-2025)
Figure 38. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Region (2020-2025)
Figure 39. Global Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025)
Figure 40. North America Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Rapid Diagnostic Testing for Influenza Sales Market Share by Country in 2024
Figure 43. North America Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Rapid Diagnostic Testing for Influenza Market Size by Country in 2024
Figure 45. U.S. Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Rapid Diagnostic Testing for Influenza Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Rapid Diagnostic Testing for Influenza Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Rapid Diagnostic Testing for Influenza Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Rapid Diagnostic Testing for Influenza Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Rapid Diagnostic Testing for Influenza Sales Market Share by Country in 2024
Figure 53. Europe Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Rapid Diagnostic Testing for Influenza Market Size by Country in 2024
Figure 55. Germany Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Rapid Diagnostic Testing for Influenza Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Rapid Diagnostic Testing for Influenza Sales Market Share by Region in 2024
Figure 67. Asia Pacific Rapid Diagnostic Testing for Influenza Market Size by Region in 2024
Figure 68. China Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Rapid Diagnostic Testing for Influenza Sales and Growth Rate (K Units)
Figure 79. South America Rapid Diagnostic Testing for Influenza Sales Market Share by Country in 2024
Figure 80. South America Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (M USD)
Figure 81. South America Rapid Diagnostic Testing for Influenza Market Size by Country in 2024
Figure 82. Brazil Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size by Region in 2024
Figure 92. Saudi Arabia Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Rapid Diagnostic Testing for Influenza Production Market Share by Region (2020-2025)
Figure 103. North America Rapid Diagnostic Testing for Influenza Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Rapid Diagnostic Testing for Influenza Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Rapid Diagnostic Testing for Influenza Production (K Units) Growth Rate (2020-2025)
Figure 106. China Rapid Diagnostic Testing for Influenza Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Rapid Diagnostic Testing for Influenza Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Rapid Diagnostic Testing for Influenza Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Rapid Diagnostic Testing for Influenza Market Share Forecast by Type (2026-2035)
Figure 111. Global Rapid Diagnostic Testing for Influenza Sales Forecast by Application (2026-2035)
Figure 112. Global Rapid Diagnostic Testing for Influenza Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Rapid Diagnostic Testing for Influenza
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rapid Diagnostic Testing for Influenza Market Size (M USD), 2025-2035
Figure 5. Global Rapid Diagnostic Testing for Influenza Market Size (M USD) (2020-2035)
Figure 6. Global Rapid Diagnostic Testing for Influenza Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Rapid Diagnostic Testing for Influenza Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Rapid Diagnostic Testing for Influenza Product Life Cycle
Figure 13. Rapid Diagnostic Testing for Influenza Sales Share by Manufacturers in 2025
Figure 14. Global Rapid Diagnostic Testing for Influenza Revenue Share by Manufacturers in 2025
Figure 15. Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Rapid Diagnostic Testing for Influenza Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Rapid Diagnostic Testing for Influenza Revenue in 2025
Figure 18. Industry Chain Map of Rapid Diagnostic Testing for Influenza
Figure 19. Global Rapid Diagnostic Testing for Influenza Market PEST Analysis
Figure 20. Global Rapid Diagnostic Testing for Influenza Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Rapid Diagnostic Testing for Influenza Market Share by Type
Figure 27. Sales Market Share of Rapid Diagnostic Testing for Influenza by Type (2020-2025)
Figure 28. Sales Market Share of Rapid Diagnostic Testing for Influenza by Type in 2025
Figure 29. Market Share of Rapid Diagnostic Testing for Influenza by Type (2020-2025)
Figure 30. Market Share of Rapid Diagnostic Testing for Influenza by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Rapid Diagnostic Testing for Influenza Market Share by Application
Figure 33. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Application (2020-2025)
Figure 34. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Application in 2025
Figure 35. Global Rapid Diagnostic Testing for Influenza Market Share by Application (2020-2025)
Figure 36. Global Rapid Diagnostic Testing for Influenza Market Share by Application in 2025
Figure 37. Global Rapid Diagnostic Testing for Influenza Sales Growth Rate by Application (2020-2025)
Figure 38. Global Rapid Diagnostic Testing for Influenza Sales Market Share by Region (2020-2025)
Figure 39. Global Rapid Diagnostic Testing for Influenza Market Size by Region (2020-2025)
Figure 40. North America Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Rapid Diagnostic Testing for Influenza Sales Market Share by Country in 2024
Figure 43. North America Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Rapid Diagnostic Testing for Influenza Market Size by Country in 2024
Figure 45. U.S. Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Rapid Diagnostic Testing for Influenza Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Rapid Diagnostic Testing for Influenza Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Rapid Diagnostic Testing for Influenza Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Rapid Diagnostic Testing for Influenza Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Rapid Diagnostic Testing for Influenza Sales Market Share by Country in 2024
Figure 53. Europe Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Rapid Diagnostic Testing for Influenza Market Size by Country in 2024
Figure 55. Germany Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Rapid Diagnostic Testing for Influenza Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Rapid Diagnostic Testing for Influenza Sales Market Share by Region in 2024
Figure 67. Asia Pacific Rapid Diagnostic Testing for Influenza Market Size by Region in 2024
Figure 68. China Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Rapid Diagnostic Testing for Influenza Sales and Growth Rate (K Units)
Figure 79. South America Rapid Diagnostic Testing for Influenza Sales Market Share by Country in 2024
Figure 80. South America Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (M USD)
Figure 81. South America Rapid Diagnostic Testing for Influenza Market Size by Country in 2024
Figure 82. Brazil Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size by Region in 2024
Figure 92. Saudi Arabia Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Rapid Diagnostic Testing for Influenza Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Rapid Diagnostic Testing for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Rapid Diagnostic Testing for Influenza Production Market Share by Region (2020-2025)
Figure 103. North America Rapid Diagnostic Testing for Influenza Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Rapid Diagnostic Testing for Influenza Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Rapid Diagnostic Testing for Influenza Production (K Units) Growth Rate (2020-2025)
Figure 106. China Rapid Diagnostic Testing for Influenza Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Rapid Diagnostic Testing for Influenza Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Rapid Diagnostic Testing for Influenza Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Rapid Diagnostic Testing for Influenza Market Share Forecast by Type (2026-2035)
Figure 111. Global Rapid Diagnostic Testing for Influenza Sales Forecast by Application (2026-2035)
Figure 112. Global Rapid Diagnostic Testing for Influenza Market Share Forecast by Application (2026-2035)
More Publications
Global Biliary Metal Stent Market Research Report 2024(Status and Outlook)
US$ 3,200.00
October 2026
112 pages
Global Virus Filtration Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
134 pages
Global MedicalDiagnostic Imaging Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
154 pages
Global Amalgam Dental Material Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
156 pages
Global Mumps Vaccine Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
166 pages
